A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2018
At a glance
- Drugs Adomeglivant (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms GLBG
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 26 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History